T cells from individuals in advanced stages of HIV-1 infection do not proliferate but express activation antigens in response to HIV-1-specific antigens

Journal of Acquired Immune Deficiency Syndromes and Human Retrovirology

Volumn 15, Issue 1, 1997, Pages 61-69

  Caruso, Arnaldo ^a   Licenziati, Stefano ^a   Canaris, Angelo Donato ^a   Corulli, Maria ^a   De Francesco, Maria Antonia ^a   Cantalamessa, Antonello ^b   Fallacara, Francesca ^a   Fiorentini, Simona ^a   Balsari, Andrea ^c   Turano, Adolfo ^a  

^a UNIVERSITY OF BRESCIA   (Italy)

^b Lovere Infectious Diseases Unit   (Italy)

^c UNIVERSITY OF MILAN   (Italy)

Author keywords

Activation antigen expression; CD25; CD71; Flow cytometry; HIV; Immune response; Proliferation; Soluble antigens; 3H thymidine incorporation

Indexed keywords

ANTIRETROVIRUS AGENT; VIRUS ANTIGEN;

ANTIGEN EXPRESSION; ARTICLE; CELL PROLIFERATION; CONTROLLED STUDY; DISEASE SEVERITY; DRUG RESPONSE; HUMAN; HUMAN CELL; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; MITOGENESIS; PRIORITY JOURNAL; VIROGENESIS; VIRUS REPLICATION;

HUMAN IMMUNODEFICIENCY VIRUS; HUMAN IMMUNODEFICIENCY VIRUS 1;

EID: 12644312183     PISSN: 10779450     EISSN: None     Source Type: Journal    
DOI: 10.1097/00042560-199705010-00010     Document Type: Article

References (40)

1. Walker BD, Chakrabarti S, Moss B, et al. HIV-specific cytotoxic T lymphocytes in seropositive individuals. Nature 1987;328: 345-8.
2. Clerici M, Stocks NI, Zajac RA et al. Detection of three distinct patterns of T helper cell dysfunction in asymptomatic, human immunodeficiency virus-seropositive patients: independence of CD4 cell numbers and clinical staging. J Clin Invest 1989;84:1892-9.
3. Gruters RA, Terpstra FG, De long R, et al. Selective loss of T cell functions in different stages of HIV infection. Eur J Immunol 1990;20:1039-44.
4. - T cell population. J Immunol 1990;144:1696-702.
5. Clerici M, Wynn TA, Berzofsky JA, et al. Role of interleukin-10 in T helper cell dysfunction in asymptomatic individuals infected with the human immunodeficiency virus. J Clin Invest 1994;93: 768-75.
6. Shearer GM, Bernstein DC, Tung KSK, et al. A model for the selective loss of major histocompatibility complex self-restricted T cell immune responses during the development of acquired immune deficiency syndrome (AIDS). J Immunol 1986;137:2514-21.
7. Bentin J, Tsoukas C, McCutchan JA, et al. Impairment of T-lymphocyte responses during early infection with the human immunodeficiency virus. J Clin Immunol 1989;9:159-68.
8. Manca F, Habeshaw JA, Dalgleish AG. HIV envelope glycoprotein, antigen specific T-cell responses, and soluble CD4. Lancet 1990;335:811-5.
9. Luria S, Chambers L, Berg P. Expression of the type 1 human immunodeficiency virus nef protein in T cells prevents antigen receptor-mediated induction of interleukin 2 mRNA. Proc Natl Acad Sci USA 1991;88:5326-30.
10. Viscidi RP, Mayur K, Lederman HM, Frankel AD. Inhibition of antigen-induced lymphocyte proliferation by tat protein from HIV-1. Science 1989;246:1606-8.
11. Schuitemaker H, Koot M, Koostra NA, et al. Biological phenotype of human immunodeficiency virus type 1 clones at different stages of infection: progression of disease is associated with a shift from monocytotropic to T-cell tropic virus populations. J Virol 1992; 66:1354-60.
12. Henry M, Uthman A, Ballaun C, Stingl G, Tschachler E. Epidermal Langerhans cells of AIDS patients express HIV-1 regulatory and structural genes. J Invest Dermatol 1994;103:593-6.
13. + T cells. Science 1992,257:383-7.
14. + lymphocytes during HIV infection. Scand J Immunol 1994;40:485-90.
15. Brinckmann JE, Doblough JH, Heger BH, et al. Expression of costimulatory molecule CD28 on T cells in human immunodeficiency virus type I infection: functional and clinical correlations. J Infect Dis 1994;169:730-8.
16. Meyaard L, Schuitemaker H, Miedema F. T-cell dysfunction in HIV infection: anergy due to defective antigen-presenting cell function? Immunol Today 1993;14:161-4.
17. Uchiyama T, Nelson DL, Fleisher TA, Waldmann TA. A monoclonal antibody (anti-Tac) reactive with activated and functionally mature T cells. II. Expression of Tac antigen on activated cytotoxic killer T cells, suppressor cells, and one of two types of helper T cells. J Immunol 1981;126:1398-403.
18. Poulton TA, Gallagher A, Potts RC, Swanson Beck J. Changes in activation markers and cell membrane receptors on human peripheral blood T lymphocytes during cell cycles progression after PHA stimulation. Immunology 1988;64:419-25.
19. Salvadori S, Pizzimenti A, Cohen S, Zier KS. The control of class II expression on T-cells is independent of the regulation of Tac and the induction of proliferation. Clin Exp Immunol 1991;86:544-9.
20. Krowka JF, Cuevas B, Maron DC, et al. Expression of CD69 after in vitro stimulation: a rapid method for quantitating impaired lymphocyte responses in HIV-infected individuals. J Acquir Immune Defic Syndr 1996;11:95-104.
21. Cease KB, Margalit H, Cornette JL, et al. Helper T cell antigenic site identification in the acquired immunodeficiency syndrome virus gp120 envelope protein and induction of immunity in mice to the native protein using a 16-residue synthetic peptide. Proc Natl Acad Sci USA 1987;84:4249-53.
22. De Francesco MA, Caruso A, Dima F, et al. IFN-γ restores HIV-and non-HIV-specific cell mediated immune response in vitro and its activity is neutralized by antibodies from patients with AIDS. Scand J Immunol 1996;43:94-100.
23. Centers for Diseases Control. Revised classification system for HIV infection and expanded surveillance case definition for AIDS among adolescent and adult. MMWR Morb Mortal Wkly Rep 1993; 41:1-19.
24. Miedema F, Petit AJC, Terpstra FG, et al. Immunological abnormalities in human immunodeficiency virus (HIV)-infected asymptomatic homosexual men. J Clin Invest 1988;82:190 8-14.
25. + T helper lymphocytes in asymptomatic human immunodeficiency virus infection. Eur J Imunol 1991;21:665-70.
26. Schrezenmeier H, Ahnert-Hilger G, Fleischer B. Inactivation of a T cell receptor-associated GTP-binding protein by antibody-induced modulation of the T cell receptor/CD3 complex. J Exp Med 1988;168:817-22.
27. Arnaiz-Villena A, Timon M, Rodriguez-Gallego M, et al. Human T-cell activation deficiency. Immunol Today 1992;13:259-64.
28. Folks T, Kelly J, Benn S, et al. Susceptibility of normal human lymphocytes to infection with HTLV-III/LAV. J Immunol 1986; 136:4049-53.
29. Ho DD, Neumann AU, Perelson AS, et al. Rapid turnover of plasma virions and CD4 lymphocytes in HIV-1 infection. Nature 1995;373:123-6.
30. Wei X, Ghosh SK, Taylor ME, et al. Viral dynamics in human immunodeficiency virus type 1 infection. Nature 1995;373:117-22.
31. Zagury D, Bernard J, Leonard R, et al. Long-term cultures of HTLV-III-infected T-cells: a model of cytopathology of T-cell depletion in AIDS. Science 1986;131:850-3.
32. Stanley SK, Mario MD, Ostrowski A, et al. Effect of immunization with a common recall antigen on viral expression in patients infected with human immunodeficiency virus type 1. N Engl J Med 1996;334:1222-30.
33. Meyaard L, Otto SA, Jonker RR, et al. Programmed death of T cells in HIV-1 infection. Science 1992;257:217-9.
34. Banda NK, Bernier J, Kurahara DK, et al. Crosslinking CD4 by human immunodeficiency virus gp120 primes T cells for activation-induced apoptosis. J Exp Med 1992;176:1099-106.
35. Suhrbier A, Burrows SB, Fernan A, et al. Peptide epitope induced apoptosis of human cytotoxic T lymphocytes: implications for peripheral T cell deletion and peptide vaccination. J Immunol 1993; 150:2169-78.
36. + cytotoxic T lymphocytes is due to fratricide. J Immunol 1993;151:658-667.
37. Levy DN, Refaeli Y, Weiner DB. Extracellular Vpr protein increases cellular permissiveness to human immunodeficiency virus replication and reactivates virus from latency. J Virol 1995;69: 1243-52.
38. Kang S-M, Beverly B, Tran A-C, et al. Transactivation by AP-1 is a molecular target of T cell clonal anergy. Science 1992;257: 1134-8.
39. + T cells. Science 1996;271:1272-6.
40. + T cells. Science 1996;271:1276-8.